Results 241 to 250 of about 692,181 (344)

Battery Life of Pulse Generators in Spinal Cord Stimulation: Analysis and Comparison Between Surgical and Percutaneous Leads in Energy Efficiency. [PDF]

open access: yesJ Clin Med
Gómez González MA   +6 more
europepmc   +1 more source

Combined ablation and radiation therapy of spinal metastases: A novel multimodality treatment approach [PDF]

open access: yes, 2015
Friedman, Michael V   +5 more
core   +1 more source

Percutaneous Cytodiagnosis of Carcinoma of the Pancreas and Bile Duct

open access: green, 1978
A. Evander   +4 more
openalex   +2 more sources

Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease

open access: yesAdvanced NanoBiomed Research, EarlyView.
Peptide/antibody–drug conjugates (PADCs) combine ligand specificity and cleavable linkers to deliver drugs precisely to disease sites with minimal toxicity. While current approvals focus on oncology, this review examines their untapped potential in inflammatory diseases, detailing mechanisms of targeted delivery and highlighting advances that position ...
Yeongji Jang   +5 more
wiley   +1 more source

A Comprehensive Overview of Cellulose and Its Derivatives: Structural Features and Emerging Applications

open access: yesJournal of Applied Polymer Science, EarlyView.
From plant cell wall architecture to advanced materials: cellulose and its derivatives as versatile building blocks. ABSTRACT Growing interest in cellulose as a versatile material has driven extensive research into its chemical architecture, processing methods, mechanical properties, aggregation behavior, and structural organization, both in solution ...
Denys M. M. Fertonani   +7 more
wiley   +1 more source

Unusual Complication of Percutaneous Gastrostomy Tube Replacement. [PDF]

open access: yesACG Case Rep J
Liang SR   +5 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy